Joshua E. Reuss

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Justina X. Caushi, Jiajia Zhang, Zhicheng Ji et al. · Nature · 2021 · 547 citations · Full text

Life Sciences, Immunology, Oncology +17

Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

Valsamo Anagnostou, Noushin Niknafs, Kristen A. Marrone et al. · Nature Cancer · 2020 · 207 citations · Full text

Medicine, Immunology, Oncology +16

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Joshua E. Reuss, Valsamo Anagnostou, Tricia R. Cottrell et al. · Journal for ImmunoTherapy of Cancer · 2020 · 163 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy

Michael S. Hwang, Jenna VanLiere Canzoniero, Samuel Rosner et al. · Journal for ImmunoTherapy of Cancer · 2022 · 134 citations · Full text

Life Sciences, Immunology, Oncology +17

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

Joshua E. Reuss, Paul R. Kunk, Anne M. Stowman et al. · Journal for ImmunoTherapy of Cancer · 2016 · 96 citations · Full text

Medicine, Immunology, Oncology +17